User profiles for Norbert Galldiks

Norbert Galldiks

Professor of Neurology, University Hospital Cologne & Research Center Juelich (INM-3)
Verified email at uk-koeln.de
Cited by 13046

Role for neuronal insulin resistance in neurodegenerative diseases

…, T Kondo, J Alber, N Galldiks… - Proceedings of the …, 2004 - National Acad Sciences
Impairment of insulin signaling in the brain has been linked to neurodegenerative diseases.
To test the hypothesis that neuronal insulin resistance contributes to defects in neuronal …

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The
review examines established clinical benefit in glioma patients of PET using glucose ( 18 F-FDG) …

[HTML][HTML] EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

…, M Smits, R Dummer, T Bachelot, F Sahm, N Galldiks… - Annals of …, 2021 - Elsevier
Highlights • This Clinical Practice Guideline provides management recommendations for
patients with brain metastases from solid tumours. • The guideline covers clinical and …

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter …

…, A Weyerbrock, M Renovanz, L Bullinger, N Galldiks… - The lancet, 2019 - thelancet.com
Background There is an urgent need for more effective therapies for glioblastoma. Data
from a previous unrandomised phase 2 trial suggested that lomustine-temozolomide plus …

[HTML][HTML] Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG …

…, J Arbizu, R Boellaard, A Drzezga, N Galldiks… - European journal of …, 2019 - Springer
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …

Advances in neuro-oncology imaging

KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key limitations: …

Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice

…, T Debeir, M Sastre, N Galldiks… - Journal of …, 2006 - Soc Neuroscience
Locus ceruleus (LC) degeneration and loss of cortical noradrenergic innervation occur early
in Alzheimer’s disease (AD). Although this has been known for several decades, the …

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors

…, H Li, C Dittmar, G Garlip, N Galldiks… - Journal of Nuclear …, 2005 - Soc Nuclear Med
Because of the high glucose metabolism in normal brain tissue 18 F-FDG is not the ideal
tracer for the detection of gliomas. Methyl- 11 C-l-methionine ( 11 C-MET) is better suited for …

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET

N Galldiks, V Dunkl, G Stoffels, M Hutterer… - European journal of …, 2015 - Springer
Purpose The follow-up of glioblastoma patients after radiochemotherapy with conventional
MRI can be difficult since reactive alterations to the blood–brain barrier with contrast …

Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI

N Galldiks, KJ Langen, R Holy, M Pinkawa… - Journal of Nuclear …, 2012 - Soc Nuclear Med
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …